Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
Dr Gil Morgan - Skåne University Hospital, Lund, Sweden
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020 ( Dr Gil Morgan - Skåne University Hospital, Lund, Sweden )
9 Nov 2020
Evolving concepts in the diagnosis and staging of multiple myeloma
Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Evolving concepts in the diagnosis and staging of multiple myeloma ( Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
6 Nov 2020
Recommendations on treating multiple myeloma patients during the pandemic
Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Recommendations on treating multiple myeloma patients during the pandemic ( Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
6 Nov 2020
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-sma...
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
Sotorasib for advanced non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
Sotorasib for advanced non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
CaRE2 Cancer Research Link©: Social Determinants of Health on Cancer Outcomes in...
Kenneth Stokes, Lynette Jones and Dr Herman Tucker
CaRE2 Cancer Research Link©: Social Determinants of Health on Cancer Outcomes in Black Populations ( Kenneth Stokes, Lynette Jones and Dr Herman Tucker )
4 Nov 2020
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Prospective validation of single mouse testing by the paediatric preclinical tes...
Dr Peter Houghton - Greehey Children's Cancer Institute, San Antonio, USA
Prospective validation of single mouse testing by the paediatric preclinical testing consortium ( Dr Peter Houghton - Greehey Children's Cancer Institute, San Antonio, USA )
4 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020
The ENA virtual meeting 2020
Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
The ENA virtual meeting 2020 ( Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation
Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation ( Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
4 Nov 2020